Girancitug
Product Specifications
CAS Number
3024821-77-7
Target
VEGFR
Related Pathways
Tyrosine Kinase/Adaptors, Angiogenesis
Bioactivity
Girancitug is a humanized IgG1κ monoclonal antibody inhibitor that targets VEGFR2/KDR/CD309. It effectively suppresses angiogenesis and is applicable in anti-angiogenic therapy research for cancers such as colorectal and ovarian cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
